Eye Ultherapy 200 shots + Re2O Fine 2ccUnder-eye & eye area · in Gangnam, Seoul
Eye Ultherapy 200 shots with Re2O Fine 2cc brings firmness and fine-line concerns into one consultation. First establish which areas, if any, need each treatment. At QD Clinic in Gangnam, Seoul, South Korea, consultation helps determine which options suit your concerns.
Who it’s for
- Concerned about both eye-area laxity and fine lines in thin skin
- Want to discuss whether Eye Ultherapy 200 shots and Re2O Fine 2cc are each needed
- Need a plan that accounts for previous eye-area treatments and recovery
Suitability requires an examination. Skin thickness, health and previous procedures may make a different approach more appropriate.
How it works
Eye Ultherapy 200 shots + Re2O Fine 2cc. Re2O Fine is an ECM product made from human acellular dermal matrix (hADM). This package includes 2cc; the area is selected after assessing the skin and product instructions. Shots and cc describe the package components. Areas, sequence and same-day suitability are decided at consultation; combining treatments does not guarantee additional benefit. Shot counts across devices do not represent equal energy. Eye Ultherapy PRIME uses ultrasound imaging to assess brow laxity and supporting tissue, with a modest brow lift as a possible goal. Avoid the eyes, eyelids and inside the orbital rim. A shallower transducer does not make direct eyelid treatment appropriate.
THE MECHANISM, STEP BY STEP
01The product and material
Re2O Fine is an ECM product made from human acellular dermal matrix (hADM). This package includes 2cc; the area is selected after assessing the skin and product instructions.
02Your starting point
Eye-area laxity for Ultherapy and thin-skin or fine-line concerns for Re2O Fine, assessed as separate areas. Eye Ultherapy PRIME uses ultrasound imaging to assess brow laxity and supporting tissue, with a modest brow lift as a possible goal. Avoid the eyes, eyelids and inside the orbital rim. A shallower transducer does not make direct eyelid treatment appropriate. Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Product instructions, eyelid function and previous treatments guide suitability. Inclusion in this menu does not mean every product is injected directly under the eyes.
03What sets it apart
Map the energy-treatment and injection areas separately. Check previous products, sites, dates and residual swelling before deciding sequence or same-day treatment. No fixed interval or additional benefit is assumed.
04Assessing the change
Review energy-related reactions separately from injection swelling and texture. Early swelling alone does not establish benefit or the need for more product; examination and follow-up photographs guide the next plan. With ECM products, the immediate appearance is distinguished from the settled tissue response. Timing depends on the area, skin and formulation. Session count and spacing depend on examination, the specific product instructions and your response. Allow recovery time before an important event or journey.
Treatment areas
- Under-eye & eye area
- Eye-area laxity for Ultherapy and thin-skin or fine-line concerns for Re2O Fine, assessed as separate areas. Eye Ultherapy PRIME uses ultrasound imaging to assess brow laxity and supporting tissue, with a modest brow lift as a possible goal. Avoid the eyes, eyelids and inside the orbital rim. A shallower transducer does not make direct eyelid treatment appropriate. Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Product instructions, eyelid function and previous treatments guide suitability. Inclusion in this menu does not mean every product is injected directly under the eyes. 2cc is the listed package quantity, not 2cc per eye or a mandatory 1cc on each side. Injection sites and allocation are confirmed after examination.
What the procedure is like
- 1Bring details of puffiness, dry eyes, previous filler or surgery and medicines. Share event and travel dates so recovery time and follow-up can be planned together.
- 2Map the energy-treatment and injection areas separately. Check previous products, sites, dates and residual swelling before deciding sequence or same-day treatment. No fixed interval or additional benefit is assumed.
- 3After appropriate comfort measures and cleansing, the doctor treats the agreed areas. 2cc is the listed package quantity, not 2cc per eye or a mandatory 1cc on each side. Injection sites and allocation are confirmed after examination.
- 4Persistent swelling or discomfort should be assessed before further treatment. Keep these product differences in mind when discussing your aftercare. Review energy-related reactions separately from injection swelling and texture. Early swelling alone does not establish benefit or the need for more product; examination and follow-up photographs guide the next plan.
Appointment length depends on consultation, numbing and treatment extent. Tell us your available time and important plans when booking.
Recovery & aftercare
- Heat, pain, redness, swelling and tenderness can occur. Recovery depends on the person and area; burns or persistent sensory changes are possible. Severe eye pain or visual changes need urgent assessment.
- Injection marks, redness, swelling, bruising, tenderness or temporary bumps can occur; recovery varies.
- Avoid strong irritation, overheating and strenuous exercise while the skin settles. Follow your instructions for washing and makeup.
- Massage and pressure advice differs by product. Follow your clinician’s instructions rather than another product’s routine.
- Review energy-related reactions separately from injection swelling and texture. Early swelling alone does not establish benefit or the need for more product; examination and follow-up photographs guide the next plan.
What to expect over time
A general guide to how the days and months after treatment usually unfold. Results vary by individual.
Immediately
Heat, pain, redness, swelling and tenderness can occur. Recovery depends on the person and area; burns or persistent sensory changes are possible. Severe eye pain or visual changes need urgent assessment.
Early recovery
Injection marks, redness, swelling, bruising, tenderness or temporary bumps can occur; recovery varies. Avoid strong irritation, overheating and strenuous exercise while the skin settles. Follow your instructions for washing and makeup. Massage and pressure advice differs by product. Follow your clinician’s instructions rather than another product’s routine.
Review
Review energy-related reactions separately from injection swelling and texture. Early swelling alone does not establish benefit or the need for more product; examination and follow-up photographs guide the next plan.
Next steps
Session count and spacing depend on examination, the specific product instructions and your response. Allow recovery time before an important event or journey.
Sessions & results
Review energy-related reactions separately from injection swelling and texture. Early swelling alone does not establish benefit or the need for more product; examination and follow-up photographs guide the next plan. With ECM products, the immediate appearance is distinguished from the settled tissue response. Timing depends on the area, skin and formulation. Session count and spacing depend on examination, the specific product instructions and your response. Allow recovery time before an important event or journey.
How it compares
Eye Ultherapy PRIME uses ultrasound imaging to assess brow laxity and supporting tissue, with a modest brow lift as a possible goal. Avoid the eyes, eyelids and inside the orbital rim. A shallower transducer does not make direct eyelid treatment appropriate. Re2O Fine is an ECM product made from human acellular dermal matrix (hADM). This package includes 2cc; the area is selected after assessing the skin and product instructions.
| Comparison | Eye Ultherapy 200 shots + Re2O Fine 2cc | Eye Ultherapy PRIME |
|---|---|---|
| Selection | Eye Ultherapy PRIME uses ultrasound imaging to assess brow laxity and supporting tissue, with a modest brow lift as a possible goal. Avoid the eyes, eyelids and inside the orbital rim. A shallower transducer does not make direct eyelid treatment appropriate. Re2O Fine is an ECM product made from human acellular dermal matrix (hADM). This package includes 2cc; the area is selected after assessing the skin and product instructions. | Eye Ultherapy PRIME uses ultrasound imaging to assess brow laxity and supporting tissue, with a modest brow lift as a possible goal. Avoid the eyes, eyelids and inside the orbital rim. A shallower transducer does not make direct eyelid treatment appropriate. |
Neither is “better” — they work differently and suit different goals. The right choice is decided after we assess your skin.
Safety & considerations
Possible reactions
- Infection, persistent nodules, unevenness, inflammation or allergic reactions can occur.
- Injections carry rare but serious risks including vascular injury or blockage and tissue damage.
- Heat, pain, redness, swelling and tenderness can occur. Recovery depends on the person and area; burns or persistent sensory changes are possible. Severe eye pain or visual changes need urgent assessment.
- Their areas are assessed separately. Ultherapy instructions restrict treatment of the eyes, eyelids and within the orbital rim, including techniques that could deliver energy to the eye. Considering an injection at a site does not make it suitable for ultrasound. A listed shot count does not justify treating restricted areas. Ultherapy also cautions against treatment directly over dermal fillers. Confirm the eligible area and whether the package is appropriate before proceeding.
When to take extra care
- Disclose pregnancy or breastfeeding, allergies, immune conditions, medicines, previous fillers and threads.
- Active inflammation or infection at the site needs assessment before treatment is scheduled.
- Map the energy-treatment and injection areas separately. Check previous products, sites, dates and residual swelling before deciding sequence or same-day treatment. No fixed interval or additional benefit is assumed.
Worsening pain, pale or mottled skin, visual symptoms or breathing difficulty need urgent medical attention. Outcomes and duration vary; a specific result is not guaranteed. Their areas are assessed separately. Ultherapy instructions restrict treatment of the eyes, eyelids and within the orbital rim, including techniques that could deliver energy to the eye. Considering an injection at a site does not make it suitable for ultrasound. A listed shot count does not justify treating restricted areas. Ultherapy also cautions against treatment directly over dermal fillers. Confirm the eligible area and whether the package is appropriate before proceeding.
Your care at QD Clinic
Start with the concern
Eye-area laxity for Ultherapy and thin-skin or fine-line concerns for Re2O Fine, assessed as separate areas. Eye Ultherapy PRIME uses ultrasound imaging to assess brow laxity and supporting tissue, with a modest brow lift as a possible goal. Avoid the eyes, eyelids and inside the orbital rim. A shallower transducer does not make direct eyelid treatment appropriate. Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Product instructions, eyelid function and previous treatments guide suitability. Inclusion in this menu does not mean every product is injected directly under the eyes.
Understand your product
2cc is the listed package quantity, not 2cc per eye or a mandatory 1cc on each side. Injection sites and allocation are confirmed after examination.
Plan through recovery
Map the energy-treatment and injection areas separately. Check previous products, sites, dates and residual swelling before deciding sequence or same-day treatment. No fixed interval or additional benefit is assumed. Review energy-related reactions separately from injection swelling and texture. Early swelling alone does not establish benefit or the need for more product; examination and follow-up photographs guide the next plan.
Frequently asked questions
Their areas are assessed separately. Ultherapy instructions restrict treatment of the eyes, eyelids and within the orbital rim, including techniques that could deliver energy to the eye. Considering an injection at a site does not make it suitable for ultrasound.
Ultherapy imaging supports tissue assessment for ultrasound treatment. It does not establish injection suitability or sites. Skin thickness, previous injections and product instructions need a separate assessment.
The original package uses PN-based Rejuran I and PDLLA/HA-based Juvelook I. This option includes hADM-based Re2O Fine 2cc instead of those two products. Total volume alone cannot establish which composition is preferable.
A listed shot count does not justify treating restricted areas. Ultherapy also cautions against treatment directly over dermal fillers. Confirm the eligible area and whether the package is appropriate before proceeding.
Often considered together
Treatments that are sometimes planned alongside this one, decided at consultation.
+Under-eye & eye area
Eye Ultherapy PRIME uses ultrasound imaging to assess brow laxity and supporting tissue, with a modest brow lift as a possible goal. Avoid the eyes, eyelids and inside the orbital rim. A shallower transducer does not make direct eyelid treatment appropriate. Re2O Fine is an ECM product made from human acellular dermal matrix (hADM). This package includes 2cc; the area is selected after assessing the skin and product instructions.
For international patients
Consultation in English / 中文 / 日本語 · WhatsApp · WeChat · KakaoTalk · a 4-minute walk from Sinnonhyeon / Nonhyeon Station (hours in KST).
How many days should I stay?
Surgery and course-based treatments need a check-up. We tell you before you book whether that means staying longer or coming back another time.
For International Patients